Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Revenue

Kazia Therapeutics had revenue of $15.65K in the twelve months ending December 31, 2023. In the fiscal year ending June 30, 2023, Kazia Therapeutics had annual revenue of $15.86K, a decrease of -15.40%.

• Revenue (ttm): $15.65K
• Revenue Growth: -15.40%
• P/S Ratio: 410.78
• Revenue / Employee: $1,739
• Employees: 9
• Market Cap: 6.43M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	15.86K	-2.89K	-15.40%
Jun 30, 2022	18.75K	-11.43M	-99.84%
Jun 30, 2021	11.45M	10.72M	1,464.64%
Jun 30, 2020	731.72K	-370.39K	-33.61%
Jun 30, 2019	1.10M	-8.61M	-88.65%
Jun 30, 2018	9.71M	2.93M	43.28%
Jun 30, 2017	6.78M	3.75M	123.58%
Jun 30, 2016	3.03M	840.77K	38.39%
Jun 30, 2015	2.19M	1.79M	441.96%
Jun 30, 2014	404.14K	-1.18M	-74.45%
Jun 30, 2013	1.58M	-844.31K	-34.80%
Jun 30, 2012	2.43M	-63.43K	-2.55%
Jun 30, 2011	2.49M	972.97K	64.15%
Jun 30, 2010	1.52M	-509.24K	-25.13%
Jun 30, 2009	2.03M	-12.27M	-85.83%
Jun 30, 2008	14.30M	-2.69M	-15.82%
Jun 30, 2007	16.99M	3.44M	25.41%
Jun 30, 2006	13.54M	95.39K	0.71%
Jun 30, 2005	13.45M	2.03M	17.75%
Jun 30, 2004	11.42M	-4.84M	-29.77%
Jun 30, 2003	16.26M	2.58M	18.86%
Jun 30, 2002	13.68M	-5.37M	-28.17%
Jun 30, 2001	19.05M	3.04M	18.97%
Jun 30, 2000	16.01M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.